Preoperative Nomogram to Risk Stratify Patients for the Benefit of Trimodality Therapy in Esophageal Adenocarcinoma

PURPOSE: To develop a nomogram that estimates 1-year recurrence-free survival (RFS) after trimodality therapy for esophageal adenocarcinoma and to assess the overall survival (OS) benefit of esophagectomy after chemoradiotherapy (CRT) on the basis of 1-year recurrence risk. METHODS: In total, 568 co...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ann Surg Oncol
Autors principals: Goense, Lucas, van Rossum, Peter S. N., Xi, Mian, Maru, Dipen M., Carter, Brett W., Meijer, Gert J., Ho, Linus, van Hillegersberg, Richard, Hofstetter, Wayne L., Lin, Steven H.
Format: Artigo
Idioma:Inglês
Publicat: Springer International Publishing 2018
Matèries:
Gastrointestinal Oncology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5928173/
https://ncbi.nlm.nih.gov/pubmed/29569125
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-018-6435-4
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars